Vaccines, Blood & Biologics
-
2007 Safety and Availability Communications
This webpage was developed to provide the public with important information about the safety and availability of biological products.
-
- Interim Recommendations for the Use of Haemophilus influenzae Type b (Hib) Conjugate Vaccines Related to the Recall of Certain Lots of Hib-Containing Vaccines (PedvaxHIB® and Comvax®)
MedWatch Safety Alerts for Human Medical Products FDA Statement on Gene Therapy Clinical Trial [ARCHIVED]Potential Risk of Variant Creutzfeldt-Jakob Disease (vCJD) From Plasma-Derived Products [ARCHIVED]FDA Public Health Notification: Unpredictable Events in Medical Equipment due to New Daylight Saving Time Change [ARCHIVED]Advice for Patients: Change in Daylight Saving Time May Affect Your Medical Equipment in an Unpredictable Way [ARCHIVED]FDA Public Health Notification: Information on RotaTeq and Intussusception [ARCHIVED]- Postmarketing Monitoring of Intussusception After RotaTeq™ Vaccination --- United States, February 1, 2006--February 15, 2007
-
-
-
